Order Article Reprints

Trojani A, Pungolino E, Di Camillo B, Bossi LE, Palumbo C, D’adda M, Perego A, Turrini M, Elena C, Borin LM, et al. Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects. Cancers. 2025; 17(6):1022. https://doi.org/10.3390/cancers17061022

Trojani, Alessandra, Ester Pungolino, Barbara Di Camillo, Luca Emanuele Bossi, Cassandra Palumbo, Mariella D’adda, Alessandra Perego, Mauro Turrini, Chiara Elena, Lorenza Maria Borin, and et al. 2025. "Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects" Cancers 17, no. 6: 1022. https://doi.org/10.3390/cancers17061022

Trojani, A., Pungolino, E., Di Camillo, B., Bossi, L. E., Palumbo, C., D’adda, M., Perego, A., Turrini, M., Elena, C., Borin, L. M., Iurlo, A., Malato, S., Spina, F., Latargia, M. L., Spedini, P., Artale, S., Anghilieri, M., Carraro, M. C., Bucelli, C., ... Cairoli, R. (2025). Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects. Cancers, 17(6), 1022. https://doi.org/10.3390/cancers17061022